Quote | MaxCyte Inc. (NASDAQ:MXCT)
Last: | $4.40 |
---|---|
Change Percent: | 0.0% |
Open: | $4.63 |
Close: | $4.40 |
High: | $4.7 |
Low: | $4.4 |
Volume: | 333,238 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | MaxCyte Inc. (NASDAQ:MXCT)
ROCKVILLE, Md., July 09, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioproce...
ROCKVILLE, Md., May 29, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bio...
Message Board Posts | MaxCyte Inc. (NASDAQ:MXCT)
Subject | By | Source | When |
---|---|---|---|
AviseAnalytics: MAXCYTE: A PIONEER IN THE CELL THERAPY MARKET $MXCT Excited to share an article ab | AviseAnalytics | investorshangout | 04/17/2023 12:47:21 PM |
MAXCYTE: A PIONEER IN THE CELL THERAPY MARKET $MXCT Excited to share an article about MaxCyte, | | mwn | 04/17/2023 9:37:30 AM |
znewcar1: MXCT 20% v829K c12.88 f100M H12.92 nasdaq | znewcar1 | investorshangout | 11/11/2021 10:39:59 PM |
chartguy89: MAXC 0.09 Stock Charts $MAXC 1 Month Chart | chartguy89 | investorshangout | 03/08/2014 2:12:39 PM |
chartguy89: MAXC Stock Charts Last: UNCH Thursday, February 27, 2014 at 5:33:19 PM $MAXC 1 M | chartguy89 | investorshangout | 02/27/2014 10:33:30 PM |
News, Short Squeeze, Breakout and More Instantly...
ROCKVILLE, Md., July 09, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioproce...
ROCKVILLE, Md., May 29, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bio...
ROCKVILLE, Md., May 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc . , (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics and inn...